In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank’s whole genome sequencing. He discusses the challenges and innovations in genomic data analysis, highlighting Illumina’s role in advancing genetic research and precision medicine.
Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis
In people with a rare condition called light chain amyloidosis, light chain proteins-;which are a component of antibodies-;mutate and build up in different organs.
July 10, 2024